Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-6 av 6

2019
1 Drivenes, Karin; Haaland, Vegard Øksendal; Mesel, Terje; Tanum, Lars Håkon Reiestad.
Practitioners' positive attitudes promote shared decision-making in mental health care. Journal of Evaluation In Clinical Practice 2019 ;Volum 25. s. 1041-1049
OSLOMET APOTEKSØ UiO SSHF UIA AHUS Untitled
 
2 Khoonsari, Payam Emaami; Musunri, Sravani; Herman, Stephanie; Svensson, Camilla I; Tanum, Lars Håkon Reiestad; Gordh, Torsten; Kultima, Kim.
Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patients. Journal of Proteomics 2019 ;Volum 190. s. 35-43
AHUS Untitled
 
3 Latif, Zill-E-Huma; Solli, Kristin Klemmetsby; Opheim, Arild; Kunøe, Nikolaj; Saltyte Benth, Jurate; Krajci, Peter; Haase, Kamni Sharma; Tanum, Lars Håkon Reiestad.
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study. American Journal on Addictions 2019 ;Volum 38.(2) s. 77-85
UiB AHUS UiO HAUKELAND OUS Untitled
 
4 Lind, Anne-Li; Just, David; Mikus, Maria; Fredolini, Claudia; Ioannou, Marina; Gerdle, Björn; Ghafouri, Bijar; Bäckryd, Emmanuel; Tanum, Lars Håkon Reiestad; Gordh, Torsten; Månberg, Anna.
CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia. Journal of Pain Research 2019 ;Volum 12. s. 2875-2889
AHUS Untitled
 
5 Skjærvø, Ingeborg; Latif, Zill-E-Huma; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad.
Forekomst av kronisk smerte blant opioidavhengige. Vettre-seminaret; 2019-11-14 - 2019-11-15
AHUS UiO Untitled
 
6 Solli, Kristin Klemmetsby; Kunøe, Nikolaj; Latif, Zill-E-Huma; Haase, Kamni Sharma; Opheim, Arild; Krajci, Peter; Gaulen, Zhanna; Saltyte Benth, Jurate; Tanum, Lars Håkon Reiestad.
Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial. European Addiction Research 2019 ;Volum 25.(6) s. 1-7
SIV AHUS OUS UiO HAUKELAND UiB OSLOMET Untitled